| abstract |
An object of the present invention is to provide an evaluation method that can provide highly reliable information that can be used as a reference for knowing the risk of developing AD in the future. In the present embodiment, α-ABA, Ala, Arg, Asn, Cit, Gin, Glu, Gly, His, Ile, Leu, Lys, Met, Orn, Phe, Pro, Ser, Thr in the blood of an evaluation subject having MCI , Trp, Tyr, Val, Cysteine, Taurine, bABA, Ethylglycine, Hypotaurine, 3-Me-His, 5-HydroxyTrp, aAiBA and N8-Acetylspermidine. Assess the onset risk. |